For research use only. Not for therapeutic Use.
Oxidized low-<wbr></wbr>density lipoprotien (oxLDL) particles contain low molecular weight species which are cytotoxic and pro-<wbr></wbr>atherogenic. Many of these substances were recently isolated and purified from oxLDL, and identified as phosphatidylcholine species containing a fragmented, oxidized short-<wbr></wbr>chain fatty acid remnant at the <em>sn</em>-<wbr></wbr>2 position. 1-<wbr></wbr>(Palmitoyl)-<wbr></wbr>2-<wbr></wbr>(5-<wbr></wbr>oxovaleroyl)-<wbr></wbr>phosphatidylcholine, or POV-<wbr></wbr>PC, is one of the oxLDL species derived from 2-<wbr></wbr>arachidonoyl or eicosapentanoyl phospholipids. POV-<wbr></wbr>PC confers CD36 scavenger receptor binding affinity more potently than any hydroperoxy PC species, and may be one of the more important structural determinants of oxLDL. Treatment of cultured endothelial cells with POV-<wbr></wbr>PC stimulates monocyte binding, stimulates intracellular cAMP production, and strongly inhibits the LPS-<wbr></wbr>induced binding of neutrophils.
| Catalog Number | R043268 |
| CAS Number | 121324-31-0 |
| Synonyms | (7R)-7-[(1,5-Dioxopentyl)oxy]-4-hydroxy-N,N,N-trimethyl-10-oxo-3,5,9-trioxa-4-phosphapentacosan-1-aminium 4-Oxide Inner Salt; ?(R)-7-[(1,5-Dioxopentyl)oxy]-4-hydroxy-N,N,N-trimethyl-10-oxo-3,5,9-trioxa-4-phosphapentacosan-1-aminium 4-Oxide Inner Salt |
| Molecular Formula | C29H56NO9P |
| Purity | ≥95% |
| Target | Apoptosis |
| Storage | -20°C |
| IUPAC Name | [(2R)-3-hexadecanoyloxy-2-(5-oxopentanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate |
| InChI | InChI=1S/C29H56NO9P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-20-28(32)36-25-27(39-29(33)21-18-19-23-31)26-38-40(34,35)37-24-22-30(2,3)4/h23,27H,5-22,24-26H2,1-4H3/t27-/m1/s1 |
| InChIKey | RKIDALSACBQVTN-HHHXNRCGSA-N |
| SMILES | CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCC=O |
